(VIANEWS) – KBC (KBC.BR), NAVAMEDIC (NAVA.OL), SONAE (SON.LS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. KBC (KBC.BR)
31.2% sales growth and 15.09% return on equity
KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company offers demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services. It also provides digital and mobile banking services. The company was formerly known as KBC Bank and Insurance Holding Company NV and changed its name to KBC Group NV in March 2005. KBC Group NV was incorporated in 1935 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, KBC has a trailing twelve months EPS of €7.68.
PE Ratio
KBC has a trailing twelve months price to earnings ratio of 6.67. Meaning, the purchaser of the share is investing €6.67 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.09%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 9.09B for the twelve trailing months.
More news about KBC.
2. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 31.69. Meaning, the purchaser of the share is investing kr31.69 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Moving Average
NAVAMEDIC’s worth is above its 50-day moving average of kr36.13 and above its 200-day moving average of kr36.95.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 454.46M for the twelve trailing months.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.40 at 12:20 EST, way under its 52-week high of kr43.90 and way above its 52-week low of kr31.00.
Sales Growth
NAVAMEDIC’s sales growth is 22.8% for the current quarter and 17.3% for the next.
More news about NAVAMEDIC.
3. SONAE (SON.LS)
10.5% sales growth and 9.35% return on equity
Sonae, SGPS, S.A. engages in retail, financial services, technology, shopping center, and telecommunications businesses. The company operates hypermarkets under the Continente brand; convenience supermarkets under the Continente Modelo and Continente Bom Dia brands; franchised supermarkets under the Meu Super brand; cafeteria under the Bagga brand; healthy food supermarkets and restaurants under the Go Natural brand; book shops and stationery under the Make Notes and Note! brands; health, well-being, and eye care centers under the Well´s brand; and dental and aesthetic medicine clinics under the Dr. Well's brand, as well as provides dog and cat products and services under the ZU brand. It also offers clothing, footwear, and accessories under the MO brand; baby and children clothing, footwear, and accessories, as well as childcare products under the Zippy and Losan brands; and jeans, clothing, and accessories under the Salsa brand. In addition, the company sells consumer electronics and entertainment products under the Worten brand; and mobile telecommunications products under the Worten Mobile brand, as well as develops real estate properties. Further, it offers payments, cards, personal loans, and insurance under the Universo brand; financing online purchases under the Universo Flex brand; and meal vouchers, gifting, and rewarding under the Da cards brand, as well as operates sports retail stores under JD, Sprinter, and Size? brand names. Additionally, the company provides telecommunication services to residential, personal, corporate, and wholesale markets; and investment management activities. It operates in Portugal, Spain, France, the United Kingdom, Germany, Italy, Romania, Brazil, Mexico, the Netherlands, and internationally. Sonae, SGPS, S.A. was founded in 1959 and is headquartered in Maia, Portugal. Sonae, SGPS, S.A. operates as a subsidiary of Efanor Investimentos SGPS, SA.
Earnings Per Share
As for profitability, SONAE has a trailing twelve months EPS of €0.12.
PE Ratio
SONAE has a trailing twelve months price to earnings ratio of 7.77. Meaning, the purchaser of the share is investing €7.77 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.35%.
Moving Average
SONAE’s worth is below its 50-day moving average of €0.95 and below its 200-day moving average of €0.97.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 8.34B for the twelve trailing months.
Sales Growth
SONAE’s sales growth is 25.6% for the ongoing quarter and 10.5% for the next.
More news about SONAE.
4. PERNOD RICARD (RI.PA)
7.9% sales growth and 13.85% return on equity
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. Pernod Ricard SA was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €9.31.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 20.92. Meaning, the purchaser of the share is investing €20.92 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.85%.
Moving Average
PERNOD RICARD’s worth is way above its 50-day moving average of €173.28 and above its 200-day moving average of €194.39.
Yearly Top and Bottom Value
PERNOD RICARD’s stock is valued at €194.80 at 12:20 EST, way below its 52-week high of €218.00 and way higher than its 52-week low of €156.35.
More news about PERNOD RICARD.
5. SPAREBANK 1 SR-BK (SRBNK.OL)
6.3% sales growth and 13.14% return on equity
SpareBank 1 SR-Bank ASA, together with its subsidiaries, provides various financial products and services for personal and corporate customers in Southern and Western Norway. The company operates through Retail customers, SME & Agriculture, and Large Corporates segments. It offers its products and services in the areas of savings, loans, insurance, and pensions. The company also provides foreign exchange, administrative securities, commercial properties, leasing, accounting, advisory, estate agency, payroll/HR, securities trading, and investments services; green loans; credit and debit cards; consulting; and banking services. In addition, it facilitates debt and equity funding; and sells real estate properties comprising holiday homes, new builds, and used homes. Further, the company is involved in the customer trading of interest rate instruments; and purchasing of home mortgages. It also serves retail and corporate, small business, and agricultural customers, as well as the public sector. The company was founded in 1839 and is headquartered in Stavanger, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SR-BK has a trailing twelve months EPS of kr14.18.
PE Ratio
SPAREBANK 1 SR-BK has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing kr8.24 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.14%.
Moving Average
SPAREBANK 1 SR-BK’s value is under its 50-day moving average of kr125.72 and below its 200-day moving average of kr123.42.
More news about SPAREBANK 1 SR-BK.
6. DASSAULT SYSTEMES (DSY.PA)
5.8% sales growth and 14.06% return on equity
Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS design software for mechanical and electronic printed circuit board design solutions, product data management, simulation, manufacturing, and technical communication; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for intersection of natural resources, infrastructure and urban planning; and BIOVIA that develops chemicals, biologics, and materials experiences. The company provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.
Earnings Per Share
As for profitability, DASSAULT SYSTEMES has a trailing twelve months EPS of €0.69.
PE Ratio
DASSAULT SYSTEMES has a trailing twelve months price to earnings ratio of 52.36. Meaning, the purchaser of the share is investing €52.36 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.06%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 29, 2023, the estimated forward annual dividend rate is 0.21 and the estimated forward annual dividend yield is 0.59%.
Sales Growth
DASSAULT SYSTEMES’s sales growth is 3.3% for the ongoing quarter and 5.8% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 3.8% and 8.8%, respectively.
Volume
Today’s last reported volume for DASSAULT SYSTEMES is 189633 which is 83.18% below its average volume of 1127770.
More news about DASSAULT SYSTEMES.
